Welcome back to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Isabel Preeshagul from Memorial Sloan Kettering Cancer Center to discuss metastatic nonsmall cell lung cancer treatment without actionable mutations in firstline settings.

They dive into the importance of comprehensive testing, strategies for using immunotherapy and chemotherapy combinations, and emerging secondline treatment options. Dr. Preeshagul shares insights on targeting KRAS G12C, HER2 mutation with TDXD, and the potential combination of ramucirumab with pembrolizumab.

Tune in for a detailed discussion on the latest advancements in nonsmall cell lung cancer treatment. Don't miss out on valuable insights from this informative episode of the Oncology Brothers podcast!

Website: http://www.oncbrothers.com/

Twitter:   / oncbrothers  

Contact us at [email protected]